This Pharma Company Stays Innovative by Doing Two Things
Harvard Business
MARCH 14, 2017
This is particularly the case in biopharmaceuticals, where turning molecules into medicines is notoriously fraught with risk, and failure. In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers.
Let's personalize your content